Coronary Artery Bypass Grafting, Coronary Artery Disease Progression, Coronary Stenosis, Percutaneous Coronary Revascularization
Conditions
Keywords
Hybrid coronary revascularization
Brief summary
This study evaluated the effectiveness and safety of Hybrid Coronary Revascularization in real-world practice.
Interventions
PROCEDUREHybrid Coronary Revascularization
Hybrid coronary revascularization (HCR) combines minimally invasive surgical coronary artery bypass grafting of the left anterior descending artery with percutaneous coronary intervention (PCI) of non-left anterior descending vessels.
Sponsors
Seung-Jung Park
CardioVascular Research Foundation, Korea
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age 20 and more * Hybrid coronary revascularization due to multivessel coronary artery disease(must include left anterior descending artery) * Written consent
Exclusion criteria
* Previous CABG(coronary artery bypass graft) * Life expectancy ≤1 year
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| a composite event of death, myocardial infarction, TVR(Target Vessel Revascularization), or stroke. | 5 years | Patients who have experienced any one of the following events are considered to have experienced the composite outcome: death, myocardial infarction, TVR(Target Vessel Revascularization), or stroke. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| All death | 5 years | — |
| Cardiac death | 5 years | — |
| Myocardial infarction | 5 years | — |
| a composite event of all death or myocardial infarction | 5 years | — |
| a composite event of cardiac death or myocardial infarction | 5 years | — |
| TVR(Target Vessel Revascularization) | 5 years | — |
| TLR(Target Lesion Revascularization) | 5 years | — |
| Stent thrombosis | 5 years | by an Academic Research Consortium (ARC) category |
| Cerebrovascular event | 5 years | — |
| Procedural success | 5 days | Procedural success is defined as \< 30% final stenosis and the absence of in-hospital event including death, Q-wave myocardial infarction or urgent repeat revascularization. |
Countries
South Korea
Outcome results
None listed